CLINICAL STUDY OF CARCINOMA IN THE MAXILLARY SINUS

With the development of reconstructive surgery and chemo-radiotherapy, the clinical results in the treatment of maxillary cancer have improved markedly. However, extension of the resection leads to a larger facial deformation, so extended resection is not necessarily the best therapy when postoperat...

Full description

Saved in:
Bibliographic Details
Published inJIBI INKOKA TEMBO Vol. 44; no. 3; pp. 180 - 189
Main Authors Yonekawa, Hiroyuki, Mitani, Hiroki, Kamata, Shin-etsu, Nigauri, Tomohiko, Hoki, Katsufumi
Format Journal Article
LanguageJapanese
Published Society of Oto-rhino-laryngology Tokyo 2001
耳鼻咽喉科展望会
Subjects
Online AccessGet full text
ISSN0386-9687
1883-6429
DOI10.11453/orltokyo1958.44.180

Cover

Abstract With the development of reconstructive surgery and chemo-radiotherapy, the clinical results in the treatment of maxillary cancer have improved markedly. However, extension of the resection leads to a larger facial deformation, so extended resection is not necessarily the best therapy when postoperative QOL is taken into consideration. In 1960, Sato et al. performed a conservative surgery called “tumor reduction in combination with intra-arterial infusion of anti-cancer drugs and radiotherapy” to obtain satisfactory clinical results while minimizing facial deformation. We started a clinical trail using Sato's method in 151 patients from 1970 to 1998, but the results have fallen short of our expectation in T3 and T4 cases. For the purpose of avoiding facial incision as much as possible and improving the local control rate, we have studied the method of reduction surgery, propriety of localized chemotherapy and radiation doses. As a result, the local control rate improved to 82% and the cumulative 5-year-survival rate to 61%. We studied factors that improved clinical results in maxillary cancer treatment. Our conclusion is as follows. The subjects included 151 cases of squamous cell carcinoma originating from the maxillary sinus which were treated at our hospital from 1970 to 1998. They were classified into 3 groups according to therapy, namely, Group A : Radiotherapy with regional chemotherapy and reduction surgery, 78 cases ; Group B : Preoperative radiotherapy with regional chemotherapy and en bloc tumor resection, 33 cases ; Group C : Preoperative radiotherapy and en bloc tumor resection, 40 cases.The local control rate for these 3 groups was 75.6%, 93.9% and 82.5% respectively. The cumulative 5-year-survival rate according to the Kaplan-Meier method was 43.1%, 69.7% and 61.0%. The proportion of T3 cases was 33%, 33% and 45% and that of T4 was, 36%, 63% and 45% respectively, there being no significant difference between the groups. Accumulated clinical experience may be accountable largely for a 20% increase in the 5-year survival rate in groups B and C in the late stage compared with group A in the early stage. However, evaluation of tumors by CT frequently made in all the cases from 1981 on wards may have considerably contributed to it.
AbstractList With the development of reconstructive surgery and chemo-radiotherapy, the clinical results in the treatment of maxillary cancer have improved markedly. However, extension of the resection leads to a larger facial deformation, so extended resection is not necessarily the best therapy when postoperative QOL is taken into consideration. In 1960, Sato et al. performed a conservative surgery called “tumor reduction in combination with intra-arterial infusion of anti-cancer drugs and radiotherapy” to obtain satisfactory clinical results while minimizing facial deformation. We started a clinical trail using Sato's method in 151 patients from 1970 to 1998, but the results have fallen short of our expectation in T3 and T4 cases. For the purpose of avoiding facial incision as much as possible and improving the local control rate, we have studied the method of reduction surgery, propriety of localized chemotherapy and radiation doses. As a result, the local control rate improved to 82% and the cumulative 5-year-survival rate to 61%. We studied factors that improved clinical results in maxillary cancer treatment. Our conclusion is as follows. The subjects included 151 cases of squamous cell carcinoma originating from the maxillary sinus which were treated at our hospital from 1970 to 1998. They were classified into 3 groups according to therapy, namely, Group A : Radiotherapy with regional chemotherapy and reduction surgery, 78 cases ; Group B : Preoperative radiotherapy with regional chemotherapy and en bloc tumor resection, 33 cases ; Group C : Preoperative radiotherapy and en bloc tumor resection, 40 cases.The local control rate for these 3 groups was 75.6%, 93.9% and 82.5% respectively. The cumulative 5-year-survival rate according to the Kaplan-Meier method was 43.1%, 69.7% and 61.0%. The proportion of T3 cases was 33%, 33% and 45% and that of T4 was, 36%, 63% and 45% respectively, there being no significant difference between the groups. Accumulated clinical experience may be accountable largely for a 20% increase in the 5-year survival rate in groups B and C in the late stage compared with group A in the early stage. However, evaluation of tumors by CT frequently made in all the cases from 1981 on wards may have considerably contributed to it.
With the development of reconstructive surgery and chemo-radiotherapy, the clinical results in the treatment of maxillary cancer have improved markedly. However, extension of the resection leads to a larger facial deformation, so extended resection is not necessarily the best therapy when postoperative QOL is taken into consideration. In 1960, Sato et al. performed a conservative surgery called “tumor reduction in combination with intra-arterial infusion of anti-cancer drugs and radiotherapy” to obtain satisfactory clinical results while minimizing facial deformation. We started a clinical trail using Sato's method in 151 patients from 1970 to 1998, but the results have fallen short of our expectation in T3 and T4 cases. For the purpose of avoiding facial incision as much as possible and improving the local control rate, we have studied the method of reduction surgery, propriety of localized chemotherapy and radiation doses. As a result, the local control rate improved to 82% and the cumulative 5-year-survival rate to 61%. We studied factors that improved clinical results in maxillary cancer treatment. Our conclusion is as follows. The subjects included 151 cases of squamous cell carcinoma originating from the maxillary sinus which were treated at our hospital from 1970 to 1998. They were classified into 3 groups according to therapy, namely, Group A : Radiotherapy with regional chemotherapy and reduction surgery, 78 cases ; Group B : Preoperative radiotherapy with regional chemotherapy and en bloc tumor resection, 33 cases ; Group C : Preoperative radiotherapy and en bloc tumor resection, 40 cases.The local control rate for these 3 groups was 75.6%, 93.9% and 82.5% respectively. The cumulative 5-year-survival rate according to the Kaplan-Meier method was 43.1%, 69.7% and 61.0%. The proportion of T3 cases was 33%, 33% and 45% and that of T4 was, 36%, 63% and 45% respectively, there being no significant difference between the groups. Accumulated clinical experience may be accountable largely for a 20% increase in the 5-year survival rate in groups B and C in the late stage compared with group A in the early stage. However, evaluation of tumors by CT frequently made in all the cases from 1981 on wards may have considerably contributed to it. 当科での上顎癌の治療は1940年代から放射線を主体とした方法から始まり, 当時の治療成績は5年租生存率で30%台にとどまっており, 顔面疲痕拘縮や骨髄炎も高率にみられた。治療成績向上と顔面形態・機能保存の両立を目指し, 1960年代後半からは佐藤らの三者併用療法をmodifiedした形の治療法を行い, その成績は, 1970年から1980年までの症例で5年累積生存率41.8%が得られていたが, さらなる向上を目指しCT, MRIによる画像診断を取り入れ, それまでの単純および断層写真と視診による診断に基づく三者併用療法から, 初診時の腫瘍の進展範囲をCT等で正確に把握し, 術前療法を施行しながらその効果に応じた切除を行う方法に切り替えた。その結果, 1981年から1998年までの一塊切除症例では化学療法併用の有無の違いによりそれぞれ5年累積生存率69.7%, 61.0%が得られ, それまでの成績に対し20%以上の向上を果たした。上顎近傍には眼球等の重要臓器があり, 顔面形態の保存を含めたQOLを考慮した切除と根治性のさらなる向上が求められており, 当科における上顎癌治療法の変遷と成績について報告する。
Author Kamata, Shin-etsu
Mitani, Hiroki
Yonekawa, Hiroyuki
Nigauri, Tomohiko
Hoki, Katsufumi
Author_FL 三谷 浩樹
鎌田 信悦
米川 博之
苦瓜 知彦
保喜 克文
Author_FL_xml – sequence: 1
  fullname: 三谷 浩樹
– sequence: 2
  fullname: 鎌田 信悦
– sequence: 3
  fullname: 苦瓜 知彦
– sequence: 4
  fullname: 保喜 克文
– sequence: 5
  fullname: 米川 博之
Author_xml – sequence: 1
  fullname: Yonekawa, Hiroyuki
  organization: Division of Head and Neck, Cancer Institute Hospital, Tokyo
– sequence: 1
  fullname: Mitani, Hiroki
  organization: Division of Head and Neck, Cancer Institute Hospital, Tokyo
– sequence: 1
  fullname: Kamata, Shin-etsu
  organization: Division of Head and Neck, Cancer Institute Hospital, Tokyo
– sequence: 1
  fullname: Nigauri, Tomohiko
  organization: Division of Head and Neck, Cancer Institute Hospital, Tokyo
– sequence: 1
  fullname: Hoki, Katsufumi
  organization: Division of Head and Neck, Cancer Institute Hospital, Tokyo
BackLink https://cir.nii.ac.jp/crid/1390001204949906048$$DView record in CiNii
BookMark eNpNkE1PwkAURScGExH5By66cFt8b2aYj2VTwTYpJYGSyGoyDIMWsTVtN_x7SzDGzb2bk5uTe08GVV15Qh4RJoh8yp7r5tTVn-ca9VRNOJ-gghsyRKVYKDjVAzIEpkSohZJ3ZNy25Q5gqqQWQg4JjbM0T-MoC9bF5mUbLOdBHK3iNF8uoiDNgyKZBYvoLc2yaLUN1mm-WT-Q24M9tX782yNSzGdFnITZ8vWyFB4pxS60vYdWgExSdxBABe1lPTqn5H4nd4JRz7W3QFFT61GCEhyFcBb3WkhgI_J0na3K0rjyksg0ACAFrrnWIICrHkuu2LHt7Ls33035ZZuzsU1XupM3_98xnBt2jV7uD3EftjG-Yj_U7Vyc
ContentType Journal Article
Copyright Oto-rhino-laryngology Tokyo
Copyright_xml – notice: Oto-rhino-laryngology Tokyo
DBID RYH
DOI 10.11453/orltokyo1958.44.180
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 上顎癌治療法の変遷と成績
DocumentTitle_FL 上顎癌治療法の変遷と成績
EISSN 1883-6429
EndPage 189
ExternalDocumentID 130003795192
article_orltokyo1958_44_3_44_3_180_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
RJT
OK1
RYH
ID FETCH-LOGICAL-j221t-a1809801372cf60262453e1cc87db7b632e49ea02192ae170864166ca1d96703
ISSN 0386-9687
IngestDate Fri Jun 27 00:56:28 EDT 2025
Wed Sep 03 06:29:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j221t-a1809801372cf60262453e1cc87db7b632e49ea02192ae170864166ca1d96703
OpenAccessLink https://www.jstage.jst.go.jp/article/orltokyo1958/44/3/44_3_180/_article/-char/en
PageCount 10
ParticipantIDs nii_cinii_1390001204949906048
jstage_primary_article_orltokyo1958_44_3_44_3_180_article_char_en
PublicationCentury 2000
PublicationDate 2001-00-00
PublicationDateYYYYMMDD 2001-01-01
PublicationDate_xml – year: 2001
  text: 2001-00-00
PublicationDecade 2000
PublicationTitle JIBI INKOKA TEMBO
PublicationTitleAlternate O.R.L.Tokyo
PublicationTitle_FL OTO-RHINO-LARYNGOLOGY, TOKYO
耳鼻咽喉科展望
ORL, Tokyo
O.R.L.Tokyo
OTO-RHINO-LARYNGOLOGY,TOKYO
耳展
PublicationYear 2001
Publisher Society of Oto-rhino-laryngology Tokyo
耳鼻咽喉科展望会
Publisher_xml – name: Society of Oto-rhino-laryngology Tokyo
– name: 耳鼻咽喉科展望会
References 17) 八尾和雄, 高橋廣臣, 岡本牧人, 稲木勝英 : 北里方式による減量手術を中心に.頭頸部腫瘍19 : 36-40, 1993.
14) 安田秀男, 相川通, 桑畑直史, 鹿野真人, 大谷巌 : 当科における上顎癌の統計的観察.耳鼻臨床補83 : 138-144, 1995.
7) 森田守, 宮田守 : 上顎洞癌に対する集学治療の現状.耳鼻臨床87 : 1459-1468, 1994.
11) 酒井俊一 : 上顎癌治療の理念-ライプワークを語る-.耳鼻40 : 719-725, 1994.
5) 朝倉光司, 永見徹夫, 原渕保明, 久々湊靖, 坪田大, 他 : 上顎癌の治療成績耳鼻臨床補84 : 87-92, 1995.
18) 今野昭義, 花沢秀, 岡本美孝, 寺田修久, 戸川清, 他 : 上顎洞癌の集学的療法におけるCDDP動注化学療法の意義耳鼻35 : 737-744, 1989.
20) 朝倉光司, 三部重雄, 砂金秀充 : 当科における上顎洞扁平上皮癌の治療成績耳鼻臨床81 : 1461-1466, 1988.
3) 坂口正範, 根津公教, 河原田和夫, 谷内山仁 : 5-FU持続動注と照射による上顎洞癌治療の遠隔成績耳鼻臨床補38 : 122-127, 1990.
4) 立花文寿, 堀洋二, 木下道子, 山下利幸, 幸田純治, 他 : 徳島大学における上顎洞癌の臨床統計的観察.耳鼻臨床補61 : 146-152, 1993.
21) 今野昭義, 花沢秀, 岡本美孝, 島田加代子, 寺田修久, 他 : 上顎洞癌の集学的治療.癌と化学療法14 : 1772-1780, 1987.
12) 真崎規江, 茶谷正史, 又吉嘉伸, 久保和子, 渕端和子, 他 : 上顎癌の持続動注化学療法と放射線併用治療の長期観察例における検討.頭頸部腫瘍18 : 27-32, 1992.
2) 奥出芳博, 白戸勝, 高橋光明, 林達哉, 海野徳二 : 上顎癌の治療成績.耳鼻臨床補15 : 67-76, 1987.
25) 鎌田信悦 : 鼻副鼻腔癌に対する頭蓋底外科癌の臨床44 : 1309-1315, 1998.
23) 宮田守, 安田豊稔, 西野宏, 井上耕, 菅原公明, 他 : 二回手術法と経上顎洞頭蓋底郭清を中心に.頭頸部腫瘍19 : 41-45, 1993.
13) 瀬成田雅光, 安積靖敏, 藤平一也, 高橋和彦, 大久保英樹, 他 : 当科における上顎癌の臨床検討.耳展42 (補1) : 32-36, 1999.
16) 高橋廣臣, 岡本牧人, 鈴木徹, 斎藤彰, 八尾和雄, 他 : 上顎癌の治療成績-3年治癒とその治癒に影響する臨床的, 病理組織学的因子について-.日耳鼻84 : 869-876, 1981.
24) 田崎英生 : 放射線治療.頭頸部II, 副鼻腔癌, 放射線医学 (第2版), 梅垣洋一郎, 倉光一郎編 : 医学書院, 東京, 1967,340.
1) 佐藤靖雄 : 上顎癌の三者併用療法.耳鼻15 : 312-323, 1970.
6) 今野昭義, 仲野公一, 三浦巧, 寺田修久, 岡本美孝 : 進展上顎洞癌に対する集学療法-遠隔成績と治療上の問題点-.頭頸部腫瘍19 : 27-35, 1993.
8) 高橋廣臣, 岡本牧人, 八尾和雄, 稲木勝英 : 上顎癌の治療成績-とくに放射線照射との関連について-.耳鼻臨床補42 : 168-173, 1991.
15) 森田守 : 上顎癌の合併療法.耳鼻29 : 286-288, 1983.
22) 石井正則 : 上顎洞癌134例の臨床的検討.耳展27 (補4) : 407-423, 1984.
9) 宮田守, 森田守 : 上顎癌併用療法における動注化学療法および照射療法の意義JOHNS 9 : 591-601, 1993.
10) 松浦鎮, 牧野総太郎, 佐竹文介, 清水龍一 : 上顎がんの集学的治療と各治療法の担う役割-頭頸部外科の立場から-.癌の臨床32 : 1737-1741, 1986.
19) 三宅浩郷 : 上顎癌の治療をめぐる諸問題.日耳鼻78 : 1426-1428, 1984.
References_xml – reference: 21) 今野昭義, 花沢秀, 岡本美孝, 島田加代子, 寺田修久, 他 : 上顎洞癌の集学的治療.癌と化学療法14 : 1772-1780, 1987.
– reference: 18) 今野昭義, 花沢秀, 岡本美孝, 寺田修久, 戸川清, 他 : 上顎洞癌の集学的療法におけるCDDP動注化学療法の意義耳鼻35 : 737-744, 1989.
– reference: 16) 高橋廣臣, 岡本牧人, 鈴木徹, 斎藤彰, 八尾和雄, 他 : 上顎癌の治療成績-3年治癒とその治癒に影響する臨床的, 病理組織学的因子について-.日耳鼻84 : 869-876, 1981.
– reference: 4) 立花文寿, 堀洋二, 木下道子, 山下利幸, 幸田純治, 他 : 徳島大学における上顎洞癌の臨床統計的観察.耳鼻臨床補61 : 146-152, 1993.
– reference: 10) 松浦鎮, 牧野総太郎, 佐竹文介, 清水龍一 : 上顎がんの集学的治療と各治療法の担う役割-頭頸部外科の立場から-.癌の臨床32 : 1737-1741, 1986.
– reference: 15) 森田守 : 上顎癌の合併療法.耳鼻29 : 286-288, 1983.
– reference: 17) 八尾和雄, 高橋廣臣, 岡本牧人, 稲木勝英 : 北里方式による減量手術を中心に.頭頸部腫瘍19 : 36-40, 1993.
– reference: 6) 今野昭義, 仲野公一, 三浦巧, 寺田修久, 岡本美孝 : 進展上顎洞癌に対する集学療法-遠隔成績と治療上の問題点-.頭頸部腫瘍19 : 27-35, 1993.
– reference: 9) 宮田守, 森田守 : 上顎癌併用療法における動注化学療法および照射療法の意義JOHNS 9 : 591-601, 1993.
– reference: 24) 田崎英生 : 放射線治療.頭頸部II, 副鼻腔癌, 放射線医学 (第2版), 梅垣洋一郎, 倉光一郎編 : 医学書院, 東京, 1967,340.
– reference: 13) 瀬成田雅光, 安積靖敏, 藤平一也, 高橋和彦, 大久保英樹, 他 : 当科における上顎癌の臨床検討.耳展42 (補1) : 32-36, 1999.
– reference: 22) 石井正則 : 上顎洞癌134例の臨床的検討.耳展27 (補4) : 407-423, 1984.
– reference: 19) 三宅浩郷 : 上顎癌の治療をめぐる諸問題.日耳鼻78 : 1426-1428, 1984.
– reference: 2) 奥出芳博, 白戸勝, 高橋光明, 林達哉, 海野徳二 : 上顎癌の治療成績.耳鼻臨床補15 : 67-76, 1987.
– reference: 8) 高橋廣臣, 岡本牧人, 八尾和雄, 稲木勝英 : 上顎癌の治療成績-とくに放射線照射との関連について-.耳鼻臨床補42 : 168-173, 1991.
– reference: 23) 宮田守, 安田豊稔, 西野宏, 井上耕, 菅原公明, 他 : 二回手術法と経上顎洞頭蓋底郭清を中心に.頭頸部腫瘍19 : 41-45, 1993.
– reference: 14) 安田秀男, 相川通, 桑畑直史, 鹿野真人, 大谷巌 : 当科における上顎癌の統計的観察.耳鼻臨床補83 : 138-144, 1995.
– reference: 20) 朝倉光司, 三部重雄, 砂金秀充 : 当科における上顎洞扁平上皮癌の治療成績耳鼻臨床81 : 1461-1466, 1988.
– reference: 1) 佐藤靖雄 : 上顎癌の三者併用療法.耳鼻15 : 312-323, 1970.
– reference: 25) 鎌田信悦 : 鼻副鼻腔癌に対する頭蓋底外科癌の臨床44 : 1309-1315, 1998.
– reference: 7) 森田守, 宮田守 : 上顎洞癌に対する集学治療の現状.耳鼻臨床87 : 1459-1468, 1994.
– reference: 12) 真崎規江, 茶谷正史, 又吉嘉伸, 久保和子, 渕端和子, 他 : 上顎癌の持続動注化学療法と放射線併用治療の長期観察例における検討.頭頸部腫瘍18 : 27-32, 1992.
– reference: 3) 坂口正範, 根津公教, 河原田和夫, 谷内山仁 : 5-FU持続動注と照射による上顎洞癌治療の遠隔成績耳鼻臨床補38 : 122-127, 1990.
– reference: 5) 朝倉光司, 永見徹夫, 原渕保明, 久々湊靖, 坪田大, 他 : 上顎癌の治療成績耳鼻臨床補84 : 87-92, 1995.
– reference: 11) 酒井俊一 : 上顎癌治療の理念-ライプワークを語る-.耳鼻40 : 719-725, 1994.
SSID ssib005879667
ssib005902162
ssib005879668
ssib058493089
ssib029852170
ssj0066717
ssib007484760
ssib002004161
Score 1.4751688
Snippet With the development of reconstructive surgery and chemo-radiotherapy, the clinical results in the treatment of maxillary cancer have improved markedly....
SourceID nii
jstage
SourceType Publisher
StartPage 180
SubjectTerms en bloc tumor resection
maxillary cancer
reduction surgery
survival rate
三者併用療法
上顎癌
生存率
Title CLINICAL STUDY OF CARCINOMA IN THE MAXILLARY SINUS
URI https://www.jstage.jst.go.jp/article/orltokyo1958/44/3/44_3_180/_article/-char/en
https://cir.nii.ac.jp/crid/1390001204949906048
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX JIBI INKOKA TEMBO, 2001/06/15, Vol.44(3), pp.180-189
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELZgvPCChgAx2FAeeKtSmsRN7MeuGmqpugotSHuLnDbZ3NIYlVQC_nq-i5M0g0n8kCqrTRvLPl_P3zl33zH21lOrADg9cHmeD-GgZKkr0zSjWi853JFc8Kpo3_wynHziH66H14dw2yq7pEz7yx_35pX8z6riGtaVsmT_YWXbTnEB77G-aLHCaP9qjcdNWuNVQw09ptJAhdmqJn5xrr5RXaEdTIQuaie_waLT82lvejlbzEa9-GJ-vmiFr4EYdW-id2ajW4usgG1V7-pWF25W2nIp9oHGDTET9WKzNbd6Y1o9wb0Uq_F1n--3-s7hwuFYoYkZxcgXpXF36Ny4NNrixnJDxWbz3XSMVSBCV4b15plZYypE4MK_kV1ra9kea60KOqbTsxWd6l3Ys4WFfjfwvCrTYXafSxoAUeX0Oe-3N9-hzqZHdYMgAoiU2KUf-VHkUdTn7GPHwyLCsU5q71BEcACjXz53GM8kQFGHYZGoWKODh-lLATx0MIGAdzIYEKG_BQfouioC3Yqrzuakab27Z1LARWt4CUT_8LDQugN94mP2pPZZnJFVwKfswVo9Y36jfE6lfI7JnVb5HF04UD6nVT6nUr7nLH5_EY8nbl2Aw137vle6isjdBJFS-sucapX5GGbmLZciWqVRGgZ-xmWmIBHpqwzTFiGEGS6Vt5IhtpIX7KgwRfaSORScpFIFdCsBwNNcwFuKhopHfDVQALEnbGTnmXyxJCtJ_adKukJJOE8C22Bk7U8oPxHm4ISdQUQJJooWjk11yDqo2JeIIUq8-sP3r9ljG2BIr1N2VO722RkQZ5m-qXTmJ9yVcm8
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Study+of+Carcinoma+in+the+Maxillary+Sinus&rft.jtitle=JIBI+INKOKA+TEMBO&rft.au=Mitani+Hiroki&rft.au=Kamata+Shin-etsu&rft.au=Nigauri+Tomohiko&rft.au=Hoki+Katsufumi&rft.date=2001&rft.pub=Society+of+Oto-rhino-laryngology+Tokyo&rft.issn=0386-9687&rft.eissn=1883-6429&rft.volume=44&rft.issue=3&rft.spage=180&rft.epage=189&rft_id=info:doi/10.11453%2Forltokyo1958.44.180&rft.externalDocID=130003795192
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-9687&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-9687&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-9687&client=summon